Instituto de Investigación, Desarrollo e Innovación en Biotecnología Sanitaria de Elche (IDiBE)
8 imported, source-linked research records. All imported publication dates.
8 matching research records
Topic: Immune-age biomarkers. Only records linked to Instituto de Investigación, Desarrollo e Innovación en Biotecnología Sanitaria de Elche (IDiBE) are included. Historical ingestion is still running; these are imported records, not a count of all research worldwide.
Showing 1–8 of 8 matching records. Counts update as records arrive.
Targeting the CDK4-Cyclin D Complex: A New Generation of Selective Kinase Inhibitors for Cancer Therapy
September 22, 2026 · 0 citations · Open access
Open original record →Silibinin Overcomes EMT-Driven Lung Cancer Resistance to New-Generation ALK Inhibitors
December 11, 2022 · 15 citations · Open access
Open original record →Silibinin Suppresses the Hyperlipidemic Effects of the ALK-Tyrosine Kinase Inhibitor Lorlatinib in Hepatic Cells
September 1, 2022 · 8 citations · Open access
Open original record →An inhibitor of interaction between the transcription factor NRF2 and the E3 ubiquitin ligase adapter β-TrCP delivers anti-inflammatory responses in mouse liver
July 11, 2022 · 22 citations · Open access
Open original record →Peimine, an Anti-Inflammatory Compound from Chinese Herbal Extracts, Modulates Muscle-Type Nicotinic Receptors
October 19, 2021 · 14 citations · Open access
Open original record →ERK5 signalling pathway is a novel target of sorafenib: Implication in EGF biology
October 16, 2021 · 12 citations · Open access
Open original record →Silibinin and SARS-CoV-2: Dual Targeting of Host Cytokine Storm and Virus Replication Machinery for Clinical Management of COVID-19 Patients
June 7, 2020 · 56 citations · Open access
Open original record →Potential Drugs Targeting Early Innate Immune Evasion of SARS-Coronavirus 2 via 2’-O-Methylation of Viral RNA
May 10, 2020 · 105 citations · Open access
Open original record →